FDA clears Sonavex EchoSure portable ultrasound

By Staff News Brief

Image Gallery

The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to Sonavex for its EchoSure™ ultrasound blood flow measuring system. EchoSure combines three-dimensional (3D) ultrasound imaging with advanced deep learning algorithms to automate visual and quantitative blood flow monitoring after surgery.

When combined with its EchoMark® bioresorbable markers, EchoSure eliminates the need for ultrasound expertise in order to measure blood flow, according to Baltimore-headquartered Sonavex. An EchoSure App enables surgeons to monitor patients remotely from mobile devices

Back To Top

FDA clears Sonavex EchoSure portable ultrasound.  Appl Radiol. 

By Staff News Brief| April 05, 2019
Categories:  Section

About the Author

Staff News Brief

Staff News Brief

Copyright © Anderson Publishing 2022